chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021 at 4:18 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Mar-2021 at 4:06 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 28-Feb-2021 Age of patient was reported as 28.21 and on 28-Mar-2021 Age of patient was reported as 28.29. No concomitant medications were reported.  On 28-Feb-2021 at 09:00 A.M., the temperature recorded was 27 degree Fahrenheit and at 01:00 P.M., the temperature recorded was 26 degree Fahrenheit vial was initially moved to the fridge on 24-Feb-2021 and beyond use date was 26-Mar-2021. Product moved to clinic on 27-Feb-2021.  On 28-Mar-2021 at 10:00 A.M., the temperature recorded was 35 degree Fahrenheit, and vial was initially moved to the fridge on 23-Mar-2021 and beyond use date was 22-Apr-2021.Product moved to clinic on 27-Mar-2021.  Vial was stored on cooler 1, on 28-Feb-2021, Excursion duration At 9 AM: 27, 10 AM: 40, 11 AM: 44, 12 AM: 46, 1PM: 26, 2 PM : 37, 3 PM: 43, 4 PM: 45.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.
Severe muscle cramping in lower back and thigh that would not relent. Lasted for a week. Had to go to the ER on day 3 to make sure it wasn't kidney stones or something more serious
I am experiencing what I currently understand to be symptoms of "COVID Arm". Raised red area around the injection site. First occurring eight days after the first dose was received. I am also experiencing itchiness and some soreness to touch. It should be noted that I had pain and soreness immediately after receiving the first dose. This included a throbbing pain going down to my forearm. When discussing the experience with co-workers who also received the first dose at that time, they seemed not to experience as much pain or soreness and no one else spoke of throbbing pain.
C/o tingling, numbness on one side of face & arm. 10 minutes after receiving the flu vaccine. Pt does not have any allergies. Pt rec'd vaccination in (R) arm and c/o numbness on (R) side.
Pain on movement, especially trying to reach up, in right arm around and below injection site; Ache in shoulder and neck; Ache in shoulder and neck; Headache; Pain on movement, especially trying to reach up, in my right arm around and below injection site; Fatigue; Muscle soreness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received unspecified dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE BIONTECH, Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 20Mar2021 at 10:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included diabetes 2, fibromyalgia and arthritis on an unknown date. It was also reported that the patient was allergic to blue dyes in food and medicine on an unknown date. Concomitant medications were not provided. Patient was receiving prescribed medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 12:15, patient experienced muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue. Treatment received for the events muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue were unknown. The outcome of the events muscle soreness, pain on movement especially trying to reach up in right arm around and below injection site, ache in shoulder and neck, headache and fatigue was not recovered at the time of report.   Information about lot/batch number cannot be obtained. No further information is expected.
Swelling, pain, redness & heat at injection site  5 inches in diameter. Started 7 days after receiving the vaccine.
painful headache, swollen lymph nodes in armpit, fever over 101, chills, extreme fatigue
Arm swelling, redness morning after immunization. Pt applied ice. Evaluated in clinic for subsequent cellulitis.
Patient received Moderna for first dose of vaccine and was given pfizer as a second dose for the series
Very sore arm for 2 days. Third day showed much improvement, just some mild tenderness
Rash began 10/8/14 - started on cheeks and moved downward - Associated symptoms fever at night, decreased appetite and malaise. Follow-up appt 10/15/14 - S/s resolved - only faint flushing remains on cheeks.
Administered a vaccine that has been refrozen; A spontaneous report was received from a nurse concerning a 53-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was administered with vaccine that has been refrozen.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot: 025J20-2A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.  On 31 Dec 2020, the nurse reported she had been storing the mRNA-1273 vaccines at -20 degrees Celsius but discovered that prior to the vaccine administration facility receiving the vaccines on 24 Dec 2020, they had been stored at 38.2 degrees Fahrenheit at another facility. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered with vaccine that has been refrozen, was considered resolved on 28 Dec 2020.; Reporter's Comments: This report refers to a case 53-year-old, female administered a vaccine that has been refrozen for mRNA-1273, lot # 025J20-2A. There were no reported adverse events associated with this case of administered a vaccine that has been refrozen.
pt recvd vax 1230 pt stated that felt shakey & strange sensation all over; something not right treated w/DPH; EKG done (nl); pt felt better p/lying down for 15mins;
This spontaneous report as received from a nurse regarding unspecified number of patients of unknown age. Concurrent conditions and medical history were not reported. On an unknown dates, the unspecified number of patients were vaccinated with (Oka/Merck) VARIVAX (subcutaneous injection, dosage regimen, strength, route, lot # and expiry date were not reported) that was stored improperly (inappropriate product storage). No adverse events were reported. No further information was provided. This case is one of the several reports from same reporter. Follow-up information has been received from a nurse on 13-AUG-2014. The nurse was able to provide lot numbers for (Oka/Merck) VARIVAX (lot # J013907, expiration date: 30-OCT-2015; lot # reported as J014152, expiration date not reported). The nurse was unable to provide patient identifiers or dates of vaccinations. Follow up information has been received. It was confirmed that lot number J013907 (expiration date: 30-OCTG-2015) was valid for (Oka/Merck) VARIVAX. This case is related to 1408USA005761 (with lot # J014152) (Same Reporter Link). Additional information has been requested.
Starting on the day of the vaccine 1st dose, nothing significant initially.  About 12 hours later around midnight, I had chills, horrible headache and muscle aches.  I woke up the next morning and malaise and extreme fatigue for about 24 hours and it slowly went.  I would wake up at 2am about 4 or 5 nights with excruciating headaches and took Advil for relief.   I had symptoms for a total of 5 days but th 1st 2 days was the worst with symptoms all day long.   I had the same experience with the 2nd vaccine but no headaches with the 2nd vaccine.
Exactly a week later, I noticed I had a 2 inch lump underneath my chin where my lymph node, it was tender to the touch. on 1/5th, I can still feel the lump, but is not longer tender to the touch. I also developed blisters ( almost like herpes like) on the R side of my nose and on the inside of my nose. I never had blisters in my life, or herpes like blisters on my face. Now on 1/5/21, the blisters are starting to dry, but are still there. I as ask to contact you guys to see if I can get my second dose.
Patient received first dose of vaccine on 2/8/2021. Was monitored properly with no adverse reaction, but had a stroke a few hours later after leaving facility. Patient is still hospitalized.
Known family exposure.  Nausea, vomiting, diarrhea, weakness, SOB, cough
Info has been received from an LPN concerning her niece, a 6 year old female, who was vaccinated with a dose of varicella virus vaccine live. Subsequently, the pt experienced mild case of varicella. The nurse reported that her nephew also experienced a mild case of varicella after vaccination. Additional info has been requested.
Area of redness approx 1/2 inch from injection site. Size approx 2.5 in in diameter. No other s/sx of reaction. No fever, N/V/D. Child eating/drinking normally. Triage recommended Tylenol and mindful watching.  Parent brought child in 8/19/20 to reassure no adverse SE, vital WNL
This initial non-serious spontaneous case, received on 19-Sep-2017, reported by a pharmacist and concerns a male patient of unknown age. Patient's medical history was not reported. The pharmacist reported that, AFLURIA QUADRIVALENT about 100 doses were received, 20 doses were administered and three patients experienced the events. On 12-Sep-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, batch number: XF30506 (as reported), expiry date: 29-Jun-2018, route of administration, anatomical location was not reported). On 20-Sep-2017, after administration, the patient was extremely sick with symptoms hot and cold flashed, malaise. The patient had headache, nausea, fever, sweats, chills. It was reported that, the patient went to emergency room. The outcome of the events were recovered. Follow-up report received on 27-Sep-2017: Start date of the product administered (12-Sep-2017) and start date of the event (20-Sep-2017) was updated. The events nausea and fever were added. Amended narrative accordingly. Case correction received on 11-Oct-2017: Event sweats was added with start date.
This spontaneous report as received from a medical assistant refers to a 14 year old male patient with no pertinent medical history and no drug reactions or allergies. On 18-AUG-2014, the patient was vaccinated with the first dose of VAQTA (lot # reported as K004856, expiration date 04-DEC-2016) intramuscularly. The medical assistant reported that on 18-AUG-2014, the patient experienced a local reaction of about 2 or 3 inches of swelling on the arm around the injection site. The patient experienced redness and flushing on the face, neck and chest. The patient did not receive  treatment for the adverse events. There were no lab diagnosis or studies performed. The patient had recovered on 18-AUG-2014. Additional information has been requested.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 09-MAY-2016 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (lot # L040178, expiration date 18-AUG-2017). This specified lot number vaccine was exposed to temperature excursion two times. The total cumulative excursion time of the first time was 168 hours with the lowest recorded temperature of 34 Fahrenheit degree. The total cumulative excursion time of the second time was 72 hours with the lowest recorded temperature of 31 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse event was reported. This is one of several reports received from the same source. Additional information has been requested.
Patient received vaccine and went out and sat down in chair. I was back in IMZ room wiping it down when fellow associate knocked on door and said patient was having a seizure. I rushed out to check on him. He remain seated and I just made sure he didn't fall out of chair. It lasted about 10 seconds while I was there then pt regained control of himself. Tech called 911 and alerted store management. Asst Mgr arrived and stayed with him until paramedics came to check him out.
Pt. received vaccine 3/16 (PREVNAR 13) and stated no s/s. (PM) 3/20 states started itching in left arm area where vaccine received. 3/21 states started itching with redness at vaccine site. Purchased and used BENADRYL cream without relief of s/s. 3/22 s/s worsened. Was seen at clinic (AM) Dx with cellulitis Rx given: Prednisone 10mg Doxycycline 100mg BID.
Not in left arm at injection site light pink rash approximately 2? x 3? sensitive to touch warm to touch: Taking Tylenol 500 mg Q4 hours
Patient reports having tremors in neck and down right arm, lastly 30 secs.  Two weeks later patient ( around 10/24/2021) was found to be driving on the wrong side of the road (twice in one week).  Patient went to see PCP  and was sent to another physician for cognitive testing. He told patient that it "wasn't alzheimer's or dementia  that it was from covid."
The night of the second dose ( 12 hours later), I started experiencing fever/chills and severe right arm pain overnight after vaccine, relieved with tylenol temporarily. Fever/chills then returned (100.4 F) and was again relieved with Tylenol. Moderate myalgias, fatigue, and nausea throughout the day that remitted Thursday evening. My right arm still intermittently through today (1 week later)
Soreness under armpit, seems to be lymph node soreness. Do not feel a swollen bump though.
After I got my vaccine, I had a swollen Lymph node under my left arm. I noticed a lump on my left cheek six weeks after my second dose which turned out to be a Tumor in my Carotid gland. I was diagnosed with a Pleomorphic Adenoma. It was not painful, but it was creating discomfort. I went to the ENT, and I was diagnosed with a Pleomorphic Adenoma. I later had it surgically removed.  I had a Mammogram on 06/30/2021 and there was a lump in left my Breast. I had a normal Mammogram one year prior to this. I was Diagnosed with Cancer after Biopsy and I had Breast Surgery.
Hives began to show up on my face and scalp and progressed to entire body in 2 weeks post vaccination
Patient was given .5ml dose of lot # UTO34AA from manufacture Sanofi Pasteur, Inc.  .25ml dose should have been given.  Patient's mother contacted on 01/14/2010.  No reaction or complication noted per parent.
Confirmed Breakthrough Case  COVID-19 (Pfizer) 1  02/25/2021  EN6202   COVID-19 (Pfizer) 2  03/18/2021  EN6207
On an unspecified date, the vaccinee received a dose of Infanrix; it was not known whether the vaccinee had received previous doses of Infanrix. Subsequently, the vaccinee experienced injection site edema and redness. As of 8/31/01, the outcome of the adverse events was unknown.
been home 10 days with the flu; Initial information received on 27-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who had been home 10 days with the flu after receiving vaccine Influenza Vaccine.   The patient's past medical treatment(s), vaccination(s) and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On an unknown date, the patient received unknown dose of suspect Influenza Vaccine produced by unknown manufacturer (lot number, strength, formulation, expiry date not reported) via unknown route in unknown administration site for Flu (Influenza).  On an unknown date the patient had been home 10 days with the flu (influenza) (unknown latency) following the administration of  Influenza Vaccine (Flu shot).  It is unknown if there were lab data/results available.   Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event.   Outcome: Unknown
Pt received moderna vaccine 3/25/21. On 4/10 she experienced sudden onset dizziness that persisted for a week. on 4/15 she experienced a jolt that caused her to fall unexpectedly. She experienced headaches during this time that was unual for her.
I had my first COVID-19 vaccine on March 12th. Shortly after the injection my shoulder began hurting. I thought it was just a side effect of the vaccine injection. However, after it was still hurting 2 weeks later, I found out it's because the injection was administered incorrectly. I had my second shot on April 2nd without any complications. My shoulder is still hurting from the first shot, and my arm and fingers are tingling. The intensity of the pain has gotten better over time but I still have pain in my shoulder and tingling in my arm and fingers. My concern is if the person gave my shot incorrectly, then she has given others shots incorrectly as well. I want to know if this is going to be an ongoing issue or if my shoulder will return to normal. I contacted the hospital and was told to report the problem to VAERS.
No adverse event.  Patient received a second influenza vaccine 6 days after the first influenza vaccine.  Patient should have received the COVID vaccine instead.
Mother told me he sometimes passes out with shots - gave vaccine and after about five seconds patients head shook like a seizure with lasted less than 5 seconds then he went unconscious - the mother and I laid him on the floor and he become conscious after 15 to 20 seconds but was confused and didn't remember what happened - we helped him back to chair and he said felt a little shaky and warm - we had him sit for 5 to 10 minutes - he felt better so we moved him to a chair outside counseling room - They waited an additional 15 minutes and said felt fine - mother said had never had the seizure symptom before - advised her to call Dr and make him aware and to ask Dr about second dose - she said would get his second dose with the Dr present.
Drew up and labled vaccines for patient and sibling.  Patient was reciving 4 immunizations (DTaP, Hepatitis A, Polio, MMR) 2 in each thigh. Gave DTaP, Hepatitis A in the right thigh went to give Polio, MMR immunizations in left thigh and grabbed the immunizations drawn up for the sybling (Hepatitis A, Flu) and administered these instead of the intended vaccines.  Immediately realized what had occurred and informed patient's mother who was present in the exam room.  Patient's mother verbalized understanding of situation and agreement with patient to return at a later date to receive last dose of Polio vaccine as patient had already received 4 injections (one in error) today.  Patient was seen by PCM in Pediatrics NP immediately after leaving Immunization Clinic.  NP reviewed anaphalaxic signs and symptoms and what to watch for and be aware of with patient's mother.
Feeling tingling in fingers and toes for about two weeks. Having a lot of leg cramps since first dose.
Information has been received from a physician concerning a 21 year old female who had a negative pap smear test on 09-JAN-2006. Patient then received the first dose of GARDASIL on 02-MAR-2007 and second dose on 21-AUG-2007. Patient had a negative pap smear and negative HPV test on 21-AUG-2007. Patient received the third dose of GARDASIL on 15-JAN-2008 and she had a negative pap smear and negative HPV test on 22-APR-2008. Physician reported that on 09-APR-2009, patient had a positive HPV test for high risk, low grade squamous cell. Lot #'s were not available. The patient sought medical attention by physician. At the time of the report the patient's status was unknown. Follow-up information has been received from a pediatrician concerning the patient, she reported as having negative pap smears / negative HPV tests until after receiving the third dose of HPV. Subsequently to the third dose, the patient had positive results. The pediatrician did not know which HPV strain was detected. The patient received her doses on 02-MAR-2007 (lot # 654702/0011U), 21-AUG-2007 (lot # 656372/0243U) and 15-JAN-2008 (lot # 659653/1448U). No other vaccines were given at the time of the HPV. The outcome of the patient was unknown. The patient was referred to gynecology. No further information is available. This is one of several reports received from the same source.
On, Saturday 10/15/2022, I started to have a stomachache that felt like gas pressure. Sunday, I developed a low-grade fever and increased stomach pain. The fever stopped on 10/17/2022, but the stomach pain continued. By late afternoon, I had extreme, sharp pain and it went up into my shoulders. I went to the ER and I think they knew that I was going to be admitted. I experienced a lot of diarrhea. There was a Cat scan and they noted that the colon was perforated and that air outside of my intestines. A few days of intense pain and I was put on bowel rest, no food, no liquids. Slowly introduced liquids and today, I was able to eat solid food. Since being hospitalized the pain has become better. The nurses have told me that I may be able to go home in the next couple of days. Today is day 8 in the hospital. I was unaware that I had diverticulitis before, and I did not know until my colon perforated.